| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/2014 | US8785622 Crosslinked polysaccharides and methods of production thereof |
| 07/22/2014 | US8785620 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders |
| 07/22/2014 | US8785617 Oligomeric compounds for the modulation of HIF-1A expression |
| 07/22/2014 | US8785608 Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
| 07/22/2014 | US8785606 Compositions and methods for promoting neuronal outgrowth |
| 07/22/2014 | US8785569 Drug carrier with chelating complex micelles and the application thereof |
| 07/22/2014 | US8785505 Toxicology and cellular effect of manufactured nanomaterials |
| 07/22/2014 | US8785504 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain |
| 07/22/2014 | US8785503 Biphenyl compound or pharmaceutically acceptable salt thereof, method for preparing novel biphenyl compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient for preventing or treating diabetes complications |
| 07/22/2014 | US8785502 Compositions and methods relating to proliferative diseases |
| 07/22/2014 | US8785501 Anti-cancer tamoxifen-melatonin hybrid ligand |
| 07/22/2014 | US8785500 Intranasal administration of ketamine to treat depression |
| 07/22/2014 | US8785499 Targeting NAD biosynthesis in bacterial pathogens |
| 07/22/2014 | US8785498 L-ornithine phenyl acetate and methods of making thereof |
| 07/22/2014 | US8785497 Aqueous ophthalmic compositions containing anionic therapeutic agents |
| 07/22/2014 | US8785496 Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting |
| 07/22/2014 | US8785495 Compositions including beta-hydroxy-beta-methylbutyrate |
| 07/22/2014 | US8785494 Calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| 07/22/2014 | US8785493 Treatment of retroviral reservoirs exploiting oxidative stress |
| 07/22/2014 | US8785492 Treatment of circadian rhythm disorders |
| 07/22/2014 | US8785491 Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues |
| 07/22/2014 | US8785489 Heteroaryl substituted indole compounds useful as MMP-13 inhibitors |
| 07/22/2014 | US8785488 Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity |
| 07/22/2014 | US8785486 Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| 07/22/2014 | US8785484 Dosing regimen for a selective S1P1 receptor agonist |
| 07/22/2014 | US8785483 Methods for treating COPD |
| 07/22/2014 | US8785482 Cyclohexene benzotriazole derivatives |
| 07/22/2014 | US8785481 Ether benzotriazole derivatives |
| 07/22/2014 | US8785480 Functionalized pyridine N-oxides and processes for the preparation of the same |
| 07/22/2014 | US8785478 Viral polymerase inhibitors |
| 07/22/2014 | US8785475 Lipoic acid derivatives |
| 07/22/2014 | US8785474 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions |
| 07/22/2014 | US8785473 Plasminogen activator inhibitor-1 inhibitor |
| 07/22/2014 | US8785472 Use of dextromethorphan in treating addictive behavior or bipolar disorder |
| 07/22/2014 | US8785471 Pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 07/22/2014 | US8785470 Heterocyclic compounds and uses thereof |
| 07/22/2014 | US8785469 Method of treating atherogenic dyslipidemia |
| 07/22/2014 | US8785468 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions |
| 07/22/2014 | US8785467 Alkoxy pyrimidine PDE10 inhibitors |
| 07/22/2014 | US8785466 Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom |
| 07/22/2014 | US8785465 Pesticidal pyrimidine compounds |
| 07/22/2014 | US8785464 Pyrimidine derivatives that inhibit FAK/PTK2 |
| 07/22/2014 | US8785463 GPR 119 agonists |
| 07/22/2014 | US8785462 5-hydroxypyrimidine-4-carboxamide derivative |
| 07/22/2014 | US8785461 Process for preparing bosentan |
| 07/22/2014 | US8785460 Tricyclic compounds and use thereof |
| 07/22/2014 | US8785459 Quinazoline compounds as kinase inhibitors |
| 07/22/2014 | US8785458 Use of flibanserin in the treatment of obesity |
| 07/22/2014 | US8785457 Pyrimidine derivatives as mTOR inhibitors |
| 07/22/2014 | US8785456 Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
| 07/22/2014 | US8785455 Polymorph of linagliptin benzoate |
| 07/22/2014 | US8785454 Heterocyclic compounds and uses thereof |
| 07/22/2014 | US8785453 Arylpiperazine-containing purine derivatives and uses thereof |
| 07/22/2014 | US8785452 Anti-infective compounds |
| 07/22/2014 | US8785451 Compounds for the treatment of proliferative disorders |
| 07/22/2014 | US8785450 Therapeutic compounds and compositions |
| 07/22/2014 | US8785449 Carboxamide compounds and methods for using the same |
| 07/22/2014 | US8785448 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 07/22/2014 | US8785447 Use of dopamine D3 receptor ligands for the production of drugs for treating renal function disorders |
| 07/22/2014 | US8785446 Treating post-seizure patients |
| 07/22/2014 | US8785445 7-phenoxychroman carboxylic acid derivatives |
| 07/22/2014 | US8785444 Thiazoles and pyrazoles useful as kinase inhibitors |
| 07/22/2014 | US8785443 Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof |
| 07/22/2014 | US8785441 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| 07/22/2014 | US8785440 Bruton's tyrosine kinase inhibitors |
| 07/22/2014 | US8785438 Imidazopyridin-2-one derivatives |
| 07/22/2014 | US8785437 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 07/22/2014 | US8785436 1,3-oxazines as BACE 1 and/or BACE2 inhibitors |
| 07/22/2014 | US8785434 Antiviral compounds |
| 07/22/2014 | US8785433 Quinoline derivatives as PI3 kinase inhibitors |
| 07/22/2014 | US8785432 Pharmaceutical compositions of amlodipine and valsartan |
| 07/22/2014 | US8785431 Prodrugs of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems |
| 07/22/2014 | US8785430 Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses |
| 07/22/2014 | US8785429 Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK |
| 07/22/2014 | US8785427 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 07/22/2014 | US8785426 Testosterone gel compositions and related methods |
| 07/22/2014 | US8785425 11β-hydroxyandrosta-4-ene-3-ones |
| 07/22/2014 | US8785424 ngCycloartanone derivatives with anticancer activity |
| 07/22/2014 | US8785423 Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases |
| 07/22/2014 | US8785422 A-ring modified 19-nor-vitamin D analogs and their uses |
| 07/22/2014 | US8785420 Combination/association of adapalene and benzoyl peroxide for treating acne lesions |
| 07/22/2014 | US8785419 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 07/22/2014 | US8785418 Lyophilization cakes of proteasome inhibitors |
| 07/22/2014 | US8785416 Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases |
| 07/22/2014 | US8785415 Oral formulations of cladribine |
| 07/22/2014 | US8785414 Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome |
| 07/22/2014 | US8785406 Stabilized and lyophilized formulation of anthracycline compounds |
| 07/22/2014 | US8785405 Compounds for treating cancer and other diseases |
| 07/22/2014 | US8785404 Urea compounds |
| 07/22/2014 | US8785403 Glucopyranoside compound |
| 07/22/2014 | US8785402 Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions |
| 07/22/2014 | US8785387 Neuregulin based methods and compositions for treating cardiovascular disease |
| 07/22/2014 | US8785383 Mast cell stabilizers in the treatment of obesity |
| 07/22/2014 | US8785377 Tetrazolyl macrocyclic hepatitis C serine protease inhibitors |
| 07/22/2014 | US8785372 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 07/22/2014 | US8785371 Drug delivery of temozolomide for systemic based treatment of cancer |
| 07/22/2014 | US8785202 Colloidal metal compositions and methods |
| 07/22/2014 | US8785200 Transfection reagents |
| 07/22/2014 | US8785198 Compositions for regenerating defective or absent myocardium |
| 07/22/2014 | US8785197 Compositions for regenerating defective or absent myocardium |